These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 27098592)

  • 1. Update on the pharmacological treatment of adult myositis.
    Oddis CV
    J Intern Med; 2016 Jul; 280(1):63-74. PubMed ID: 27098592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic advances in myositis.
    Aggarwal R; Oddis CV
    Curr Opin Rheumatol; 2012 Nov; 24(6):635-41. PubMed ID: 22955021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic strategy in inflammatory myopathies (polymyositis, dermatomyositis, overlap myositis, and immune-mediated necrotizing myopathy)].
    Tournadre A
    Rev Med Interne; 2014 Jul; 35(7):466-71. PubMed ID: 24144868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of inflammatory myopathy: emerging therapies and therapeutic targets.
    Moghadam-Kia S; Aggarwal R; Oddis CV
    Expert Rev Clin Immunol; 2015; 11(11):1265-75. PubMed ID: 26313852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New therapeutic approaches for polymyositis and dermatomyositis].
    Dankó K; Vincze M
    Orv Hetil; 2011 Sep; 152(39):1552-9. PubMed ID: 21920841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developments in the classification and treatment of the juvenile idiopathic inflammatory myopathies.
    Rider LG; Katz JD; Jones OY
    Rheum Dis Clin North Am; 2013 Nov; 39(4):877-904. PubMed ID: 24182859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppressive therapy in children.
    Prasad R; Singh UK; Mittal R; Mishra OP
    J Indian Med Assoc; 2011 Feb; 109(2):101-2, 104-7. PubMed ID: 21888174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressive treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy. A nationwide retrospective analysis.
    Cocito D; Grimaldi S; Paolasso I; Falcone Y; Antonini G; Benedetti L; Briani C; Fazio R; Jann S; Matà S; Sabatelli M; Nobile-Orazio E;
    Eur J Neurol; 2011 Dec; 18(12):1417-21. PubMed ID: 21819489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating immunobullous diseases: an update.
    Reynaert S; Black MM
    Dermatol Nurs; 2004 Feb; 16(1):29-34, 70. PubMed ID: 15022502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous human immunoglobulin for the treatment of recurrent focal myositis.
    Santos-Faria D; Sousa-Neves J; Leite Silva J; Ramos Rodrigues J; Azevedo S; Alcino S; Afonso C; Teixeira F
    Acta Reumatol Port; 2019; 44(1):88-89. PubMed ID: 31249282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive drug therapy.
    McCune WJ; Vallance DK; Lynch JP
    Curr Opin Rheumatol; 1994 May; 6(3):262-72. PubMed ID: 8060760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on therapy for refractory dermatomyositis and polymyositis.
    Villalba L; Adams EM
    Curr Opin Rheumatol; 1996 Nov; 8(6):544-51. PubMed ID: 9018458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of Interstitial Lung Disease in Patients With Myositis Specific Autoantibodies.
    Mecoli CA; Christopher-Stine L
    Curr Rheumatol Rep; 2018 Apr; 20(5):27. PubMed ID: 29637383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic strategies in idiopatic inflammatory myopathies].
    Chakour R; Leimgruber A; Bart PA; Spertini F
    Rev Med Suisse; 2009 Apr; 5(199):812-8. PubMed ID: 19441746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myositis in clinical practice-relevance of new antibodies.
    Moghadam-Kia S; Aggarwal R; Oddis CV
    Best Pract Res Clin Rheumatol; 2018 Dec; 32(6):887-901. PubMed ID: 31427061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of immunomodulary agents is difficult in treating autoimmune hepatitis patients.
    Gordon FD; Simpson M
    J Clin Gastroenterol; 2004 Oct; 38(9):729-30. PubMed ID: 15365394
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapeutic approaches in myositis.
    Aggarwal R; Oddis CV
    Curr Rheumatol Rep; 2011 Jun; 13(3):182-91. PubMed ID: 21365210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Characteristics, Treatment, and Outcomes in Patients with Idiopathic Inflammatory Myopathy Concomitant with Heart Failure.
    Liu Y; Fang L; Chen W; Lin X; Wang Q; Zhu Y; Pang H; Zhang S
    Int Heart J; 2020; 61(5):1005-1013. PubMed ID: 32999188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycophenolate mofetil therapy for juvenile dermatomyositis with immune thrombocytopenic purpura.
    Ogimi C; Honma N; Tanaka R; Oh-ishi T
    Mod Rheumatol; 2012 Apr; 22(2):280-3. PubMed ID: 21710356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis and management of small vessel vasculitides].
    Pettersson T; Karjalainen A
    Duodecim; 2010; 126(12):1496-507. PubMed ID: 20617753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.